University of North Carolina at Chapel Hill-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

2006

  1. Deep brain stimulation: Postoperative issues

    Movement Disorders, Vol. 21, Núm. SUPPL. 14